Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | yes | yes: 3 |
Pissara et al. | yes | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QBU9
Term | Name | Level | Count |
---|---|---|---|
GO:0000049 | tRNA binding | 5 | 11 |
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0003824 | catalytic activity | 1 | 3 |
GO:0004812 | aminoacyl-tRNA ligase activity | 4 | 3 |
GO:0016874 | ligase activity | 2 | 3 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 3 | 3 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 3 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 3 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 394 | 398 | PF00656 | 0.599 |
CLV_MEL_PAP_1 | 266 | 272 | PF00089 | 0.411 |
CLV_NRD_NRD_1 | 215 | 217 | PF00675 | 0.592 |
CLV_NRD_NRD_1 | 277 | 279 | PF00675 | 0.383 |
CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.588 |
CLV_PCSK_KEX2_1 | 214 | 216 | PF00082 | 0.599 |
CLV_PCSK_KEX2_1 | 254 | 256 | PF00082 | 0.718 |
CLV_PCSK_KEX2_1 | 277 | 279 | PF00082 | 0.372 |
CLV_PCSK_KEX2_1 | 341 | 343 | PF00082 | 0.443 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.646 |
CLV_PCSK_PC1ET2_1 | 254 | 256 | PF00082 | 0.707 |
CLV_PCSK_PC1ET2_1 | 341 | 343 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 126 | 130 | PF00082 | 0.644 |
CLV_PCSK_SKI1_1 | 254 | 258 | PF00082 | 0.814 |
CLV_PCSK_SKI1_1 | 360 | 364 | PF00082 | 0.480 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.575 |
CLV_Separin_Metazoa | 211 | 215 | PF03568 | 0.619 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.548 |
DOC_MAPK_gen_1 | 324 | 331 | PF00069 | 0.610 |
DOC_MAPK_gen_1 | 341 | 348 | PF00069 | 0.554 |
DOC_PP1_RVXF_1 | 358 | 364 | PF00149 | 0.594 |
DOC_PP2B_LxvP_1 | 23 | 26 | PF13499 | 0.588 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.647 |
DOC_USP7_MATH_1 | 173 | 177 | PF00917 | 0.652 |
DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.587 |
DOC_USP7_MATH_1 | 193 | 197 | PF00917 | 0.749 |
DOC_USP7_MATH_1 | 200 | 204 | PF00917 | 0.707 |
DOC_USP7_MATH_1 | 205 | 209 | PF00917 | 0.615 |
DOC_USP7_MATH_1 | 379 | 383 | PF00917 | 0.594 |
DOC_USP7_UBL2_3 | 219 | 223 | PF12436 | 0.582 |
DOC_USP7_UBL2_3 | 254 | 258 | PF12436 | 0.847 |
DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.598 |
LIG_14-3-3_CanoR_1 | 133 | 137 | PF00244 | 0.486 |
LIG_14-3-3_CanoR_1 | 58 | 64 | PF00244 | 0.463 |
LIG_Actin_WH2_2 | 43 | 60 | PF00022 | 0.541 |
LIG_FHA_1 | 150 | 156 | PF00498 | 0.568 |
LIG_FHA_1 | 294 | 300 | PF00498 | 0.582 |
LIG_FHA_1 | 313 | 319 | PF00498 | 0.575 |
LIG_FHA_2 | 127 | 133 | PF00498 | 0.536 |
LIG_FHA_2 | 235 | 241 | PF00498 | 0.743 |
LIG_FHA_2 | 255 | 261 | PF00498 | 0.806 |
LIG_FHA_2 | 392 | 398 | PF00498 | 0.507 |
LIG_KLC1_Yacidic_2 | 283 | 288 | PF13176 | 0.583 |
LIG_LIR_Apic_2 | 167 | 173 | PF02991 | 0.543 |
LIG_LIR_Apic_2 | 203 | 207 | PF02991 | 0.746 |
LIG_LIR_Gen_1 | 264 | 273 | PF02991 | 0.495 |
LIG_LIR_LC3C_4 | 315 | 320 | PF02991 | 0.629 |
LIG_LIR_Nem_3 | 264 | 270 | PF02991 | 0.537 |
LIG_LIR_Nem_3 | 46 | 50 | PF02991 | 0.575 |
LIG_PCNA_PIPBox_1 | 385 | 394 | PF02747 | 0.529 |
LIG_SH2_CRK | 204 | 208 | PF00017 | 0.692 |
LIG_SH2_NCK_1 | 110 | 114 | PF00017 | 0.615 |
LIG_SH2_NCK_1 | 142 | 146 | PF00017 | 0.569 |
LIG_SH2_NCK_1 | 204 | 208 | PF00017 | 0.692 |
LIG_SH2_PTP2 | 267 | 270 | PF00017 | 0.495 |
LIG_SH2_STAP1 | 142 | 146 | PF00017 | 0.569 |
LIG_SH2_STAP1 | 367 | 371 | PF00017 | 0.621 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.599 |
LIG_SH2_STAT5 | 170 | 173 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 267 | 270 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 286 | 289 | PF00017 | 0.583 |
LIG_SH3_3 | 373 | 379 | PF00018 | 0.537 |
LIG_SUMO_SIM_anti_2 | 72 | 81 | PF11976 | 0.616 |
LIG_SUMO_SIM_par_1 | 21 | 27 | PF11976 | 0.393 |
LIG_TRAF2_1 | 207 | 210 | PF00917 | 0.621 |
LIG_TRAF2_1 | 308 | 311 | PF00917 | 0.614 |
MOD_CAAXbox | 423 | 426 | PF01239 | 0.581 |
MOD_CDK_SPxxK_3 | 60 | 67 | PF00069 | 0.597 |
MOD_CK1_1 | 149 | 155 | PF00069 | 0.586 |
MOD_CK1_1 | 21 | 27 | PF00069 | 0.557 |
MOD_CK2_1 | 108 | 114 | PF00069 | 0.633 |
MOD_CK2_1 | 126 | 132 | PF00069 | 0.358 |
MOD_CK2_1 | 205 | 211 | PF00069 | 0.567 |
MOD_CK2_1 | 21 | 27 | PF00069 | 0.509 |
MOD_CK2_1 | 234 | 240 | PF00069 | 0.779 |
MOD_CK2_1 | 254 | 260 | PF00069 | 0.721 |
MOD_Cter_Amidation | 252 | 255 | PF01082 | 0.778 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.601 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.646 |
MOD_GlcNHglycan | 185 | 188 | PF01048 | 0.710 |
MOD_GlcNHglycan | 195 | 198 | PF01048 | 0.770 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.755 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.775 |
MOD_GlcNHglycan | 300 | 303 | PF01048 | 0.351 |
MOD_GlcNHglycan | 410 | 413 | PF01048 | 0.666 |
MOD_GSK3_1 | 118 | 125 | PF00069 | 0.636 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.457 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.627 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.764 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.612 |
MOD_GSK3_1 | 379 | 386 | PF00069 | 0.607 |
MOD_GSK3_1 | 387 | 394 | PF00069 | 0.503 |
MOD_N-GLC_1 | 146 | 151 | PF02516 | 0.577 |
MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.520 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.555 |
MOD_NEK2_1 | 146 | 151 | PF00069 | 0.574 |
MOD_NEK2_1 | 261 | 266 | PF00069 | 0.623 |
MOD_NEK2_1 | 303 | 308 | PF00069 | 0.589 |
MOD_NEK2_1 | 312 | 317 | PF00069 | 0.565 |
MOD_NEK2_1 | 329 | 334 | PF00069 | 0.585 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.364 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.545 |
MOD_NEK2_2 | 262 | 267 | PF00069 | 0.407 |
MOD_PIKK_1 | 181 | 187 | PF00454 | 0.694 |
MOD_PIKK_1 | 312 | 318 | PF00454 | 0.648 |
MOD_PIKK_1 | 330 | 336 | PF00454 | 0.629 |
MOD_PKA_1 | 254 | 260 | PF00069 | 0.781 |
MOD_PKA_1 | 341 | 347 | PF00069 | 0.638 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.481 |
MOD_PKA_2 | 174 | 180 | PF00069 | 0.746 |
MOD_PKA_2 | 254 | 260 | PF00069 | 0.679 |
MOD_PKA_2 | 341 | 347 | PF00069 | 0.481 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.601 |
MOD_PKA_2 | 57 | 63 | PF00069 | 0.307 |
MOD_Plk_1 | 5 | 11 | PF00069 | 0.515 |
MOD_Plk_2-3 | 132 | 138 | PF00069 | 0.613 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.508 |
MOD_Plk_4 | 262 | 268 | PF00069 | 0.587 |
MOD_Plk_4 | 324 | 330 | PF00069 | 0.633 |
MOD_Plk_4 | 395 | 401 | PF00069 | 0.520 |
MOD_Plk_4 | 6 | 12 | PF00069 | 0.551 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.613 |
MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.593 |
MOD_SUMO_for_1 | 222 | 225 | PF00179 | 0.694 |
MOD_SUMO_rev_2 | 247 | 256 | PF00179 | 0.827 |
MOD_SUMO_rev_2 | 343 | 349 | PF00179 | 0.592 |
TRG_DiLeu_BaEn_1 | 75 | 80 | PF01217 | 0.600 |
TRG_DiLeu_BaEn_2 | 64 | 70 | PF01217 | 0.590 |
TRG_ENDOCYTIC_2 | 110 | 113 | PF00928 | 0.591 |
TRG_ENDOCYTIC_2 | 267 | 270 | PF00928 | 0.495 |
TRG_ER_diArg_1 | 213 | 216 | PF00400 | 0.608 |
TRG_ER_diArg_1 | 276 | 278 | PF00400 | 0.591 |
TRG_ER_diArg_1 | 57 | 59 | PF00400 | 0.623 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P301 | Leptomonas seymouri | 66% | 100% |
A0A0S4IJF4 | Bodo saltans | 39% | 100% |
A0A1X0NUW2 | Trypanosomatidae | 45% | 100% |
A0A3R7KNR3 | Trypanosoma rangeli | 44% | 100% |
A0A3S7WX09 | Leishmania donovani | 86% | 100% |
A4HC93 | Leishmania braziliensis | 78% | 100% |
A4HZS5 | Leishmania infantum | 86% | 100% |
C9ZRK5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9AVN0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
V5B5W2 | Trypanosoma cruzi | 37% | 100% |